
The new indication for rosuvastatin is unlikely to have any significant impact on clinical practices because of questions about its clinical utility.
Published: August 11th 2010 | Updated:
259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512
© 2025 MJH Life Sciences®
All rights reserved.